Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Rakovina Therapeutics Inc. has partnered with Variational AI to research and develop new cancer treatments utilizing AI-driven drug discovery platforms. The collaboration will focus on identifying novel small-molecule therapies targeting DNA-damage response for cancer treatment, with Rakovina Therapeutics synthesizing and evaluating drug candidates at the University of British Columbia labs.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
